Skip to main content
Premium Trial:

Request an Annual Quote

GenoLogics, Rosetta Biosoftware, BlueGnome

Premium
GenoLogics this week launched Geneus 4.0, the latest version of its lab and data management system for genomics research.
 
According to GenoLogics, Geneus 4.0 can now handle data from next-generation sequencing platforms, such as Illumina’s Genome Analyzer. The updated system also provides advanced querying and reporting capabilities along with a secure web interface to facilitate collaboration.
 

 
Rosetta Biosoftware this week launched its Syllego System Version 2.0, a software package for genetic data management and analysis.
 
Syllego allows users to integrate microarray, next-generation sequencer, and clinical data in genetic studies. According to Rosetta, the new version of Syllego has been enhanced with an expanded set of data analysis tools, a new user interface, and the ability to use server-side processing.
 

 
BlueGnome last week launched BlueFISH, a library of 26,000 pre-labeled probes for fluorescent in situ hybridization.
 
The BlueFISH library is derived from the Roswell Park Cancer Institute’s library of bacterial artificial chromosomes and allows tiling of the complete human genome.
 
BlueGnome said that the library can be used to confirm results from its CytoChip microarray platform and other microarray platforms.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.